2021 related articles for article (PubMed ID: 30681962)
21. Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO.
Younossi ZM; Afendy A; Stepanova M; Racila A; Nader F; Gomel R; Safer R; Lenderking WR; Skalicky A; Kleinman L; Myers RP; Subramanian GM; McHutchison JG; Levy C; Bowlus CL; Kowdley K; Muir AJ
Hepatology; 2018 Jul; 68(1):155-165. PubMed ID: 29152767
[TBL] [Abstract][Full Text] [Related]
22. Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden.
Cole JC; Ito D; Chen YJ; Cheng R; Bolognese J; Li-McLeod J
Health Qual Life Outcomes; 2014 Sep; 12():114. PubMed ID: 25186634
[TBL] [Abstract][Full Text] [Related]
23. Validity and test retest reliability of the vascular quality of life Questionnaire-6: a short form of a disease-specific health-related quality of life instrument for patients with peripheral arterial disease.
Kumlien C; Nordanstig J; Lundström M; Pettersson M
Health Qual Life Outcomes; 2017 Sep; 15(1):187. PubMed ID: 28962624
[TBL] [Abstract][Full Text] [Related]
24. Style preference survey: a report on the psychometric properties and a cross-validation experiment.
Smith SL; Ricketts T; McArdle RA; Chisolm TH; Alexander G; Bratt G
J Am Acad Audiol; 2013 Feb; 24(2):89-104. PubMed ID: 23357803
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
Brod M; Blum SI; Bushnell DM; Ramasamy A
Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
[TBL] [Abstract][Full Text] [Related]
26. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
[TBL] [Abstract][Full Text] [Related]
27. Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.
Andrae DA; Grace RF; Jewett A; Foster B; Klaassen RJ; Salek S; Li J; Tai F; Boscoe AN; Zagadailov E
J Patient Rep Outcomes; 2023 Nov; 7(1):112. PubMed ID: 37943362
[TBL] [Abstract][Full Text] [Related]
28. DEVELOPMENT AND VALIDATION OF 'SURE': A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE.
Neale J; Vitoratou S; Finch E; Lennon P; Mitcheson L; Panebianco D; Rose D; Strang J; Wykes T; Marsden J
Drug Alcohol Depend; 2016 Aug; 165():159-67. PubMed ID: 27344196
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
Elstein D; Belmatoug N; Deegan P; Göker-Alpan Ö; Hughes DA; Schwartz IVD; Weinreb N; Bonner N; Panter C; Fountain D; Lenny A; Longworth L; Miller R; Shah K; Schenk J; Sen R; Zimran A
Orphanet J Rare Dis; 2022 Jan; 17(1):9. PubMed ID: 34991656
[TBL] [Abstract][Full Text] [Related]
30. PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
Fuller G; Bolus R; Whitman C; Talley J; Erder MH; Joseph A; Silberg DG; Spiegel B
Dig Dis Sci; 2017 Mar; 62(3):593-606. PubMed ID: 28116591
[TBL] [Abstract][Full Text] [Related]
31. Urinary Stones and Intervention Quality of Life (USIQoL): Development and Validation of a New Core Universal Patient-reported Outcome Measure for Urinary Calculi.
Joshi HB; Johnson H; Pietropaolo A; Raja A; Joyce AD; Somani B; Philip J; Biyani CS; Pickles T
Eur Urol Focus; 2022 Jan; 8(1):283-290. PubMed ID: 33423970
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of the HDSIM™ assessment system: a measure of hemorrhoid disease symptom impact.
Schwartz CE; Borowiec K
Qual Life Res; 2024 Jun; 33(6):1481-1492. PubMed ID: 38502416
[TBL] [Abstract][Full Text] [Related]
33. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).
Whalley D; McKenna SP; Dewar AL; Erdman RA; Kohlmann T; Niero M; Cook SA; Crickx B; Herdman MJ; Frech F; Van Assche D
Br J Dermatol; 2004 Feb; 150(2):274-83. PubMed ID: 14996098
[TBL] [Abstract][Full Text] [Related]
34. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
[TBL] [Abstract][Full Text] [Related]
35. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
[TBL] [Abstract][Full Text] [Related]
36. Development and preliminary validation of the food intolerance Quality of Life Questionnaire (FIQLQ): Adult Form.
DunnGalvin A; Barnett J; Begen FM; Ryan K; Lucas JS
Qual Life Res; 2018 Apr; 27(4):1109-1116. PubMed ID: 29151148
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.
Sakane Y; Yamaguchi M; Yokoi N; Uchino M; Dogru M; Oishi T; Ohashi Y; Ohashi Y
JAMA Ophthalmol; 2013 Oct; 131(10):1331-8. PubMed ID: 23949096
[TBL] [Abstract][Full Text] [Related]
38. Development and psychometric validation of the intermittent self-catheterization questionnaire.
Pinder B; Lloyd AJ; Elwick H; Denys P; Marley J; Bonniaud V
Clin Ther; 2012 Dec; 34(12):2302-13. PubMed ID: 23178033
[TBL] [Abstract][Full Text] [Related]
39. Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review.
Strand V; Simon LS; Meara AS; Touma Z
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32591423
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Conditions Questionnaire (LTCQ): initial validation survey among primary care patients and social care recipients in England.
Potter CM; Batchelder L; A'Court C; Geneen L; Kelly L; Fox D; Baker M; Bostock J; Coulter A; Fitzpatrick R; Forder JE; Gibbons E; Jenkinson C; Jones K; Peters M
BMJ Open; 2017 Nov; 7(11):e019235. PubMed ID: 29101153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
